RE:The Good outweighs the Bad in YE datathe numbers were okay. i expect there to some improvement next quarter. it's all about approval of treosulfan right now. it can more than double revenues for this company. once approved, i expect a quick ramp up in use, couple that with our other products and hopefully new ones coming, things look really good for a company with a $100 million market cap.